INDV

Indivior Pharmaceuticals
$40.03
−$0.49 (−1.22%)Jul 27, 2026
9.2GreatMoatMint rating

MoatMint rates Indivior Pharmaceuticals (INDV) 9.2 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 9.4 out of 10.

Key metrics

The numbers that frame INDV today
Market cap
$4.88B
P/E (TTM)
19.4
EV / FCF
-27.2
Gross margin
81.3%
EV / Sales
4.0
ROIC
74.6%
Div yield
0%
52wk Low
$16.69
52wk High
$42.81

INDV stock rating

How INDV scores on quality, value, growth, momentum and financial health
9.2out of 10
Great overallHealthy business, fair priceTop 8% of ~5,000 US stocks
QualityGreat9.4/10
GrowthFair3.5/10
MomentumGreat9.3/10
ValueNeutral5.4/10
Financial HealthGood7.1/10

Growth

Revenue and earnings trend for INDV
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about INDV
Is Indivior Pharmaceuticals a good buy?
Yes. Indivior Pharmaceuticals has excellent quality and excellent momentum. Both signals support the setup. Growth looks weak, a caveat that does not overturn the setup. We think Indivior Pharmaceuticals is selling at a fair price.
What is the market capitalization of INDV?
Indivior Pharmaceuticals's market capitalization is $4.88B.
What is the P/E ratio for INDV stock?
Indivior Pharmaceuticals's current P/E ratio is 19.4.
What is the 52-week high for INDV stock?
The 52-week high for Indivior Pharmaceuticals is $42.81. The current close of $40.03 is 6.5% below that high.
What is the 52-week low for INDV stock?
The 52-week low for Indivior Pharmaceuticals is $16.69. The current close of $40.03 is 139.8% above that low.
Does INDV stock pay dividends?
Indivior Pharmaceuticals does not currently show a dividend per share in the company data.